Optimizing Appropriate Use of Medications for Veterans
Optimizing Appropriate Use of Medications for Veterans
批准号:
10200823
负责人:
MARY K. Goldstein
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-10-01 至 2022-09-30
关键词:
AddressAreaCaringCategoriesCharacteristicsChronic Kidney FailureClinicClinicalCommunity of PracticeComplementCosts and BenefitsDataDevelopmentDiabetes MellitusDiseaseDrug PrescriptionsEffectivenessEnvironmentEvaluationFosteringGeneral PopulationGoalsHealth systemHealthcareHeart failureHomeHospitalsHyperlipidemiaIncidenceInformation TechnologyInfrastructureInstitute of Medicine (U.S.)InterventionMedication ManagementMethodsMethotrexateMineralocorticoid ReceptorMonitorMorbidity - disease rateNatural experimentPatient CarePatient MonitoringPatientsPharmaceutical PreparationsPharmacistsPharmacy facilityPositioning AttributePrimary Health CareProcessProviderQualitative MethodsRecommendationRecording of previous eventsResourcesSafetyStructureSulfasalazineTestingVariantVeteransWorkbasecare systemsclinical careclinical decision supportclinical decision-makingclinical implementationclinical practicecompare effectivenesscostdashboarddesigneffectiveness evaluationformative assessmentfunctional statusgraphical user interfacehigh riskhypertension controlimplementation facilitatorsimplementation scienceimplementation strategyimprovedinnovationlearning progressionmedical specialtiesmedication safetyoperationpharmacy benefitprogramsprovider networksrandomized trialsatisfactionsupport networksupport toolstherapy design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have selected optimization of medication use as the main theme of our QUERI Program with decision
support and provider networks as foci of implementation. Our proposal will build upon existing strong
relationships between the project leads (who have a long history of conducting successful QUERI projects),
and our operations partners including Pharmacy Benefits Management (PBM), Primary Care (PC), and
Specialty Care Services.
Primary Program Goal: To optimize medication management in the VA general and Patient Aligned Care
Teams in particular using pharmacy networks and decision support tools.
While the VA has implemented many interventions to improve medication safety, medication management has
significant room for improvement. Several recommendations by the Institute of Medicine, including the wide
availability of decision support and more pharmacy involvement in prescribing have not been widely
implemented in the VA. In 2011, 12% of Veterans were prescribed a potentially inappropriate medication with
an incidence (new inappropriate medication) of 6% per year. A large variation in the quality of medication
prescribing has been noted in the VA which is comparable to the general population. There is also variation in
quality of prescribing across disease states in the VA.
Associated Goal: Value: Our underlying principle is to promote high value clinical care with all medication
related interventions. We will only recommend expansion of, or design interventions for, care strategies that
are considered a “reasonable” value (ratio of benefit and cost). We plan to improve use of high value
medications, decrease use of low-value medications and improve medication safety through:
1) Optimization and expansion of the Medication Use Evaluation Tracker (MUET) of PBM. (Project 1)
2) Implementation of Clinical Decision Support for medications commonly prescribed in PC. (Project 2)
3) Local One-Year Project: Determine optimal use of the VISN 21 Pharmacy Dashboard targeting Patient
Aligned Care Teams. (Project 3)
These projects include both innovation (clinical decision support, use of communities of practice, development
of a new Medication Use Evaluation Tracker) and evaluation of existing implementation practices. By taking
advantage of natural experiments that have occurred as different facilities implemented the MUET program
and VISN 21 Pharmacy Dashboard differently, we will be able to examine effectiveness and value of a variety
of implementation strategies.
Implementation Science Focus: Our chosen area of focus for implementation is the use of provider
networks. As described below in the Implementation Core Section, through our prior QUERI work we have
shown (in a randomized trial) how QUERI facilitation of a provider network can be successful in rolling out a
national initiative (Hospital to Home) in the VA health system. Our results demonstrate that Provider networks
can complement top down implementation strategies to improve care for Veterans. Such networks are an
unrealized opportunity to improve care, and the VA is uniquely positioned to develop and use them.
A long-term goal of the QUERI Program is to optimize infrastructure and implementation strategies using local
providers (pharmacists in Project 1), clinical decision support (Project 2) and, dashboard data (Project 3) that
can be used for a variety of clinical decisions beyond medication management such as elicitation of patient
goals of care or monitoring functional status in patients with multiple morbidities. Thus, while our program
applies directly to medication management, the methods developed and tested apply broadly to VA health care
and address VA's Blueprint for Excellence's focus on leveraging information technologies and analytics while
fostering an environment of continuous learning.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing Appropriate Use of Medications for Veterans
-
批准号:9205392
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:MARY K. Goldstein
-
依托单位:
Automating Performance Metrics for Quality Improvement in Complex Chronic Disease
-
批准号:8596733
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:MARY K. Goldstein
-
依托单位:
Center on Advancing Decision Making in Aging
-
批准号:8527647
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2004
-
负责人:MARY K. Goldstein
-
依托单位:
Center on Advancing Decision Making in Aging
-
批准号:8131647
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2004
-
负责人:MARY K. Goldstein
-
依托单位:
Center on Advancing Decision Making in Aging
-
批准号:8319385
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2004
-
负责人:MARY K. Goldstein
-
依托单位:
INTELLIGENT CRITIQUING OF CLINICAL-GUIDELINE APPLICATION
-
批准号:6045000
-
项目类别:
-
资助金额:$29.43万
-
财政年份:2000
-
负责人:MARY K. Goldstein
-
依托单位:
INTELLIGENT CRITIQUING OF CLINICAL-GUIDELINE APPLICATION
-
批准号:6530776
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2000
-
负责人:MARY K. Goldstein
-
依托单位:
INTELLIGENT CRITIQUING OF CLINICAL-GUIDELINE APPLICATION
-
批准号:6637556
-
项目类别:
-
资助金额:$27.92万
-
财政年份:2000
-
负责人:MARY K. Goldstein
-
依托单位:
Disutility of Functional Limitations in the Elderly
-
批准号:6630310
-
项目类别:
-
资助金额:$39.25万
-
财政年份:1997
-
负责人:MARY K. Goldstein
-
依托单位:
Disutility of Functional Limitations in the Elderly
-
批准号:6753489
-
项目类别:
-
资助金额:$39.25万
-
财政年份:1997
-
负责人:MARY K. Goldstein
-
依托单位:
Disutility of Functional Limitations in the Elderly
-
批准号:6509888
-
项目类别:
-
资助金额:$39.25万
-
财政年份:1997
-
负责人:MARY K. Goldstein
-
依托单位:
Disutility of Functional Limitations in the Elderly
-
批准号:6910702
-
项目类别:
-
资助金额:$39.25万
-
财政年份:1997
-
负责人:MARY K. Goldstein
-
依托单位:
Disutility of Functional Limitations in the Elderly
-
批准号:6400370
-
项目类别:
-
资助金额:$38.96万
-
财政年份:1997
-
负责人:MARY K. Goldstein
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: